Investors of Dow Inc. Urged to Join Class Action Lawsuit against Dow Chemical for Securities Fraud

Class Action Lawsuit Notice for Dow Inc. Investors

On October 26, 2025, Robbins Geller Rudman & Dowd LLP announced that investors who acquired Dow Inc. (NYSE: DOW) securities between January 30, 2025, and July 23, 2025, are invited to take part in a class action lawsuit. This legal action, titled Sarti v. Dow Inc., is based on allegations of violations of the Securities Exchange Act of 1934.

The Case Background

The Dow Inc. class action lawsuit specifically addresses claims from investors who have suffered substantial losses. The lawsuit implicates not only Dow Inc. itself but also its subsidiary, The Dow Chemical Company, and several executives. Allegations state that the defendants made false and misleading statements or neglected to declare critical financial information affecting the company's performance.

Allegations of Misrepresentation

Throughout the Class Period, Dow purportedly overstated its capability to handle macroeconomic challenges, including tariffs, while downplaying their impact on financial stability. The lawsuit asserts that these misrepresentations led to an inflated valuation of the company, creating a significant risk for those invested.

Key Events Leading to the Lawsuit

The situation escalated on June 23, 2025, when BMO Capital downgraded its recommendation for Dow from "Market Perform" to "Underperform," cutting the stock price target from $29.00 to $22.00. This decision was influenced by ongoing weakness in key markets and increasing pressure on dividends, igniting a more than 3% drop in the company's stock price.

Additionally, on July 24, 2025, Dow reported a worse-than-expected non-GAAP loss per share of $0.42, compared to analyst expectations of around $0.17 to $0.18 per share. The company's sales for the second quarter dropped from the previous year, leading to a stock price decrease of over 17%. Dow’s CEO Jim Fitterling cited ongoing market challenges and a need to halve the company's dividend as contributing factors.

The Role of the Lead Plaintiff

Under the Private Securities Litigation Reform Act of 1995, any investor who purchased Dow securities during the stated Class Period may seek appointment as a lead plaintiff in this class action. The lead plaintiff, typically the investor with the most considerable financial stake in the matter, will act on behalf of all class members, participating in the direction of the lawsuit.

It's crucial to note that participation in potential recovery is not contingent on being the lead plaintiff, thus encouragement is given to all affected investors to engage.

About Robbins Geller

Robbins Geller Rudman & Dowd LLP has grown to be one of the premier legal entities for representing investors in securities fraud cases. Recognized nationally, the firm has secured monumental recoveries for investors across various lawsuits. In 2024 alone, Robbins Geller reportedly recovered over $2.5 billion for its clients in securities-related actions, solidifying its reputation in the legal community.

For more detailed information regarding the case or to express interest in participating, affected investors are encouraged to reach out at:

- Phone: 800-449-4900
- Email: email protected]
- Website: [Robbins Geller

It’s imperative that investors act swiftly as the deadline to apply for the lead plaintiff position is set for October 28, 2025. If you have incurred losses during the class period, consider this a vital opportunity to seek justice and potential recovery through collective legal action.